Ashish holds a background in Pharmaceutical Sciences and brings over 15 years of academic and industry experience in pharmaceutical and biotechnology R&D. He has led teams in matrixed environments and represented technical functions across cross-functional programs. Ashish specializes in formulation development for nucleic acid–based therapeutics, small molecules, and cyclic peptides, with expertise in lipid and polymer nanoparticles, amorphous solid dosage forms, and controlled-release systems. He has also advanced platform technologies in high-throughput and automated screening, dry-powder formulations, and alternative administration routes, including mucosal vaccination approaches for mRNA-LNPs.
